Towards New Treatments for Infant Cancer
Babies can be born with cancer that developed in the mother’s womb. One such cancer is a disease with a long name: infantile myofibromatosis (IM).
Cancer Rx Prices Too High!
Today, people with chronic myeloid leukemia (CML) are leading pretty much normal lives. They can thank a variety of medications for being alive.
Closing In on a Cure
Someone diagnosed with any type of leukemia in the early 1960s had about a 14 percent chance of being alive five years later. Today, those chances are vastly greater.
FDA Approves New GIST Rx
The US Food and Drug Administration has approved a medication to treat gastrointestinal stromal tumors (GIST) that can’t be removed with surgery, have spread or no longer respond to existing therapies.
Children With Leukemia Have New Rx
Acute lymphoblastic leukemia (ALL) is the most common blood cancer found in children. It’s diagnosed in nearly 3,000 children in the United States every year and can progress quickly if left untreated. These kids now have a new treatment option.
FDA Approves Gleevec for Children With Acute Lymphoblastic Leukemia
The US Food and Drug Administration today approved a new use of Gleevec ( imatinib ) to treat children newly diagnosed with Philadelphia chromosome positive ( Ph +) acute lymphoblastic leukemia (ALL).
The Knife Helps Cancer Patients Make the Cut
When cancer starts to grow after treatment, it usually means genetic changes in the cancer cells have taken place. Targeted therapies designed to go after specific mutations stop working against the new changes. Now there is “provocative evidence” of an effective way to combat this biology.
Attacking Leukemia Resistance
Chronic myeloid leukemia ( CML ) is a tricky cancer because it can respond well to initial therapy, but then that drug sometimes stops working. The same thing can happen when different – second-line – drugs are used. The reason for this is that the disease tends to keep changing or mutating.
Living With a Once Deadly Leukemia
Chronic myeloid leukemia – CML – is a relatively rare blood cancer that’s diagnosed in about 5,000 Americans every year. It used to be a dire diagnosis with a poor outlook. Not anymore, though.
Lung Cancer Has a New Enemy
One of the most deadly illnesses current and past smokers can face is squamous cell lung cancer. Until now, though, no drugs have targeted the gene mutations that cause this disease
- (-) Remove Gleevec filter Gleevec
- Sprycel (15) Apply Sprycel filter
- Tasigna (14) Apply Tasigna filter
- Bosutinib (5) Apply Bosutinib filter
- Sutent (2) Apply Sutent filter
- Synribo (2) Apply Synribo filter
- Herceptin (1) Apply Herceptin filter
- Iclusig (1) Apply Iclusig filter
- Kyprolis (1) Apply Kyprolis filter
- Omapro (1) Apply Omapro filter
- Ponatinib (1) Apply Ponatinib filter
- Revlimid (1) Apply Revlimid filter
- Rituxan (1) Apply Rituxan filter
- Rituximab (1) Apply Rituximab filter
- Stivarga (1) Apply Stivarga filter
- Velcade (1) Apply Velcade filter